Lisi Group (FII) Q2 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 TU earnings summary
23 Jul, 2026Executive summary
Achieved significant improvement in results for H1 2026, with revenue up 5.7% year-over-year to €942.9M, driven by strong aerospace market activity and productivity gains.
EBIT exceeded €100M for the first time, up 22.8% year-over-year, and net income rose 62.1% to €62.4M.
Positive operating free cash flow and continued investment in capacity and inventory to support aerospace growth.
Financial highlights
Revenue: €942.9M (+5.7% year-over-year); EBITDA: €148.3M (+11.4%); EBIT: €106.2M (+22.8%).
Net income: €62.4M (+62.1%); diluted EPS: €1.34 (+67.5%).
Operating free cash flow: €5.9M (vs. -€14.3M in H1 2025); net financial debt: €265.1M (23.2% of equity).
EBITDA margin: 15.7% (vs. 14.9% in H1 2025); current operating margin: 11.3% (vs. 9.7%).
Outlook and guidance
2026 targets confirmed: aiming for a fourth consecutive year of improved key financial indicators and positive free cash flow.
Aerospace division expects continued strong demand, with focus on expanding capacity and productivity.
Automotive division prioritizes industrial reorganization and integration of new sites to adapt to market changes.
Latest events from Lisi Group
- Record aerospace growth drove Q1 2026 revenue up 10.9%, offsetting automotive weakness.FII
Q1 2026 TU23 Apr 2026 - Record revenue, profit surge, and reduced debt driven by aerospace growth and medical division sale.FII
H2 202526 Feb 2026 - Strong 9.1% revenue growth driven by aerospace, with key portfolio shifts in medical and automotive.FII
Q3 2025 TU23 Oct 2025 - Record sales and EBIT growth in H1 2025, led by aerospace, with strong outlook confirmed.FII
H1 202528 Jul 2025 - Aerospace drives 8.6% sales growth, offsetting automotive decline and medical stabilization.FII
Q3 2024 TU13 Jun 2025 - Record sales and improved margins in H1 2024, led by strong aerospace performance.FII
H1 202413 Jun 2025 - Record revenue and profit growth driven by aeronautics; outlook remains positive for 2025.FII
H2 202412 Jun 2025 - Aerospace and medical growth drove Q1 sales up 8.3%, offsetting automotive decline.FII
Q1 2025 TU6 Jun 2025